This product is a xanthine oxidase (XO) inhibitor for long-term treatment of hyperuricemia with gout symptoms.
*The following content is generated by AI and is for reference only.
Overview
Febuxostat is a non-purine selective xanthine oxidase inhibitor used to treat chronic gout. Synthesized via heterocyclic coupling, its molecular formula is C17H14N2O2S with CAS 148060-97-5.
Application
- Pharmaceutical Manufacturing: Active Pharmaceutical Ingredient (API) for oral tablets targeting hyperuricemia.
- R&D Laboratories: Reference standard for analytical method validation and stability testing.
Precautions
Contraindicated in patients taking azathioprine or mercaptopurine due to toxicity risks. Store in a cool, dry place below 25°C protected from light to maintain chemical integrity.